sig abbreviations and routes of administration Flashcards
1
Q
a
A
Before
2
Q
aa
A
Of each
3
Q
aaa
A
apply to effected area
4
Q
a.c.
A
before meals
5
Q
a.d.
A
right ear
6
Q
a.m.
A
morning
7
Q
amp
A
ampule
8
Q
aq.
A
water
9
Q
aq. dist.
A
Distilled water
10
Q
a.s.
A
left ear
11
Q
a.u.
A
Each ear
12
Q
b.i.d.
A
twice a day
13
Q
b.i.w.
A
twice a week
14
Q
c
A
with
15
Q
cc
A
cubic centimeter
16
Q
cap
A
capsule
17
Q
cd
A
cycle day
18
Q
DAW
A
dispense as written
19
Q
disc or D.C.
A
discontinue
20
Q
DS
A
double strength
21
Q
eq
A
equivalent
22
Q
elix.
A
elixir
23
Q
g or Gm
A
gram
24
Q
gr
A
grain
25
gtt
drops
26
h or hr
hour
27
h.s.
at bedtime
28
IM
intramuscular
29
inj.
injection
30
IU
international units
31
IV
intravenous
32
Kg
kilogram
33
mcg
microgram
34
mg
milligram
35
ml
milliliter
36
neb
nebulizer
37
non rep. or NR
no refills
38
o.d.
right eye
39
o.l.
left eye
40
o.s.
left eye
41
o.u.
both eyes
42
oz
ounce
43
p.c.
after meals
44
post
after
45
pr
rectally
46
p.r.n.
as required or as needed
47
pv
vaginally
48
q
every
49
qd
every day
50
qh
every hour
51
qid
four times per day
52
qod
every other day
53
qs
a sufficient quantity
54
qs ad
a sufficient quantity to make
55
r
rectal
56
s
sans (without)
57
ss
one half
58
sig
directions
59
SL
sublingual
60
stat
immediately
61
subq or SC
subcutaneous
62
supp.
suppository
63
susp.
suspension
64
tab
tablet
65
tid
three times a day
66
tiw
three times a week
67
tx
treatment
68
U
units
69
u.d. or utd or ut dict
as directed
70
wc
with meals
71
Category A
Adequate studies showed no risk to fetus
72
Category B
Animal reproduction studies failed to show risk to fetus
73
Category C
Animal reproduction studies showed adverse effects on the fetus
74
Category D
Positive evidence of human fetal risk
75
Category X
Studies have demonstrated fetal abnormalities. The risks to the fetus clearly outweigh the benefits to the mother.
76
Schedule I
No accepted medical use, lack of safety and a high potential for abuse
77
Schedule II
High potential for abuse, may lead to dependence
78
Schedule III
Potential for abuse and a moderate chance of dependency
79
Schedule IV
Low potential for abuse
80
Schedule V
Lowest potential for abuse
81
po
Oral
82
CR, ER, SR
Continuous Release, Extended Release, Slow Release
